4.0 Article

Using the ratio of means as the effect size measure in combining results of microarray experiments

期刊

BMC SYSTEMS BIOLOGY
卷 3, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1752-0509-3-106

关键词

-

资金

  1. Canadian Institutes of Health Research (CIHR) [84392]
  2. Natural Sciences and Engineering Research, Council of Canada (NSERC)
  3. Mathematics of Information Technology and Complex Systems (MITACS)
  4. Genome Canada through the Ontario Genomics Institute

向作者/读者索取更多资源

Background: Development of efficient analytic methodologies for combining microarray results is a major challenge in gene expression analysis. The widely used effect size models are thought to provide an efficient modeling framework for this purpose, where the measures of association for each study and each gene are combined, weighted by the standard errors. A significant disadvantage of this strategy is that the quality of different data sets may be highly variable, but this information is usually neglected during the integration. Moreover, it is widely known that the estimated standard deviations are probably unstable in the commonly used effect size measures ( such as standardized mean difference) when sample sizes in each group are small. Results: We propose a re-parameterization of the traditional mean difference based effect measure by using the log ratio of means as an effect size measure for each gene in each study. The estimated effect sizes for all studies were then combined under two modeling frameworks: the quality-unweighted random effects models and the quality-weighted random effects models. We defined the quality measure as a function of the detection p-value, which indicates whether a transcript is reliably detected or not on the Affymetrix gene chip. The new effect size measure is evaluated and compared under the quality-weighted and quality-unweighted data integration frameworks using simulated data sets, and also in several data sets of prostate cancer patients and controls. We focus on identifying differentially expressed biomarkers for prediction of cancer outcomes. Conclusion: Our results show that the proposed effect size measure ( log ratio of means) has better power to identify differentially expressed genes, and that the detected genes have better performance in predicting cancer outcomes than the commonly used effect size measure, the standardized mean difference (SMD), under both quality-weighted and quality-unweighted data integration frameworks. The new effect size measure and the quality-weighted microarray data integration framework provide efficient ways to combine microarray results.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据